See more : Hafnia Limited (HAFN) Income Statement Analysis – Financial Results
Complete financial analysis of Reliq Health Technologies Inc. (RQHTF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Reliq Health Technologies Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Renault SA (RNLSY) Income Statement Analysis – Financial Results
- Medacta Group SA (MOVE.SW) Income Statement Analysis – Financial Results
- Lingerie Fighting Championships, Inc. (BOTY) Income Statement Analysis – Financial Results
- Bezeq The Israel Telecommunication Corp. Ltd (BZQIY) Income Statement Analysis – Financial Results
- Benchmark Metals Inc. (BNCHF) Income Statement Analysis – Financial Results
Reliq Health Technologies Inc. (RQHTF)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.reliqhealth.com
About Reliq Health Technologies Inc.
Reliq Health Technologies Inc., a healthcare technology company, develops secure telemedicine and virtual care solutions for the healthcare market. It offers iUGO Care platform, a software as a solution that allows complex patients to receive care in the home. The company was formerly known as Moseda Technologies Inc. and changed its name to Reliq Health Technologies Inc. in May 2016. Reliq Health Technologies Inc. was incorporated in 2005 is headquartered in Hamilton, Canada.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 8.55M | 1.46M | 1.14M | 181.91K | 2.27M | 182.65K | 536.20K | 31.62K | 29.74K | 61.91K | 1.50K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 274.00 |
Cost of Revenue | 3.25M | 7.26M | 7.52M | 5.84M | 12.24M | 960.12K | 544.48K | 1.85K | 93.32K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 5.30M | -5.80M | -6.38M | -5.66M | -9.97M | -777.47K | -8.28K | 29.77K | -63.58K | 61.91K | 1.50K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 274.00 |
Gross Profit Ratio | 61.99% | -396.52% | -558.27% | -3,112.71% | -439.17% | -425.65% | -1.54% | 94.15% | -213.83% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% |
Research & Development | 2.22M | 1.73M | 1.72M | 5.15M | 1.42M | 719.41K | 447.23K | 270.20K | 432.89K | 510.83K | 172.73K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 10.03M | 10.11M | 8.82M | 7.33M | 12.00M | 1.80M | 1.84M | 4.06M | 331.33K | 517.42K | 398.62K | 812.67K | 769.08K | 663.98K | 44.57K | 0.00 | 0.00 |
Selling & Marketing | 492.65K | 515.70K | 353.48K | 274.48K | 381.68K | 311.50K | 354.60K | 211.65K | 11.24K | 10.30K | 11.67K | 42.26K | 177.38K | 31.29K | 412.00 | 0.00 | 0.00 |
SG&A | 10.52M | 4.10M | 3.06M | 2.64M | 2.40M | 1.30M | 1.97M | 4.27M | 331.33K | 517.42K | 410.29K | 854.94K | 946.46K | 695.27K | 44.98K | 109.46K | 1.00K |
Other Expenses | 888.82K | -5.64K | -58.35K | -34.40K | -32.97K | 189.88K | 18.25K | 0.00 | 0.00 | 0.00 | -2.02K | -3.61K | -28.09K | 1.67K | 0.00 | 0.00 | 0.00 |
Operating Expenses | 13.63M | 5.83M | 4.84M | 7.82M | 3.82M | 2.02M | 2.42M | 4.54M | 333.51K | 518.90K | 527.03K | 856.88K | 947.10K | 695.27K | 44.98K | 109.46K | 1.00K |
Cost & Expenses | 16.88M | 13.09M | 12.37M | 13.67M | 16.06M | 2.98M | 2.96M | 4.55M | 333.51K | 518.90K | 527.03K | 856.88K | 947.10K | 695.27K | 44.98K | 109.46K | 1.00K |
Interest Income | 76.61K | 46.62K | 36.19K | 0.00 | 25.00 | 14.48K | 0.00 | 41.28K | 43.81K | 11.00 | 2.24K | 5.74K | 1.73K | 12.31K | 13.99K | 12.69K | 274.00 |
Interest Expense | 35.28K | 46.62K | 36.19K | 0.00 | 25.00 | 14.48K | 0.00 | 41.28K | 0.00 | 1.17K | 813.00 | 1.11K | 698.00 | 631.00 | 123.00 | 113.00 | 0.00 |
Depreciation & Amortization | 115.29K | 125.76K | 445.41K | 634.16K | 634.16K | 2.05K | 6.17K | 6.17K | 2.18K | 1.49K | 938.00 | 1.94K | 639.00 | 11.28K | 123.00 | 0.00 | 0.00 |
EBITDA | -8.02M | -11.51M | -10.78M | -12.85M | -12.65M | -2.80M | -2.42M | -2.40M | -928.85K | 367.16K | 223.33K | -854.94K | -972.83K | -684.63K | -44.98K | -109.46K | -726.00 |
EBITDA Ratio | -93.79% | -786.98% | -943.01% | -7,064.61% | -607.62% | -1,532.76% | -451.51% | -14,261.37% | 311.96% | 593.03% | 14,918.30% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -264.96% |
Operating Income | -8.30M | -11.63M | -11.22M | -13.49M | -13.79M | -2.80M | -2.43M | -2.45M | -317.35K | -518.90K | -526.04K | -857.99K | -947.80K | -695.90K | -45.10K | -109.46K | -726.00 |
Operating Income Ratio | -97.01% | -795.58% | -981.98% | -7,413.23% | -607.62% | -1,533.88% | -452.66% | -7,764.22% | -1,067.26% | -838.13% | -35,139.68% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -264.96% |
Total Other Income/Expenses | 124.77K | -101.19K | 33.51K | 301.31K | -163.28K | 340.54K | -412.46K | -2.10M | -440.25K | -512.27K | -748.97K | 2.13K | -413.04K | -39.36K | 0.00 | 0.00 | 726.00 |
Income Before Tax | -8.17M | -11.78M | -11.12M | -13.00M | -13.80M | -2.46M | -2.84M | -4.56M | -757.60K | -1.40M | -1.28M | -855.86K | -1.36M | -735.26K | 0.00 | 0.00 | 0.00 |
Income Before Tax Ratio | -95.55% | -805.69% | -973.06% | -7,148.79% | -607.92% | -1,347.44% | -529.58% | -14,411.42% | -2,547.84% | -2,266.89% | -85,171.14% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | 4.00 | 239.11K | 2.00 | -2.05K | 3.00 | 1.00 | -2.02M | 424.09K | 884.57K | 747.99K | -79.38K | -138.88K | -8.98K | -13.99K | 96.88K | 726.00 |
Net Income | -8.17M | -11.78M | -11.12M | -13.00M | -13.80M | -2.46M | -2.84M | -4.56M | -757.60K | -1.40M | -1.28M | -855.86K | -1.22M | -735.26K | -31.11K | -96.88K | -726.00 |
Net Income Ratio | -95.55% | -805.69% | -973.06% | -7,148.79% | -607.92% | -1,347.44% | -529.58% | -14,411.42% | -2,547.84% | -2,266.89% | -85,171.14% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -264.96% |
EPS | -0.04 | -0.07 | -0.08 | -0.11 | -0.14 | -0.04 | -0.06 | -0.25 | -0.50 | -1.18 | -1.08 | -0.84 | -1.80 | -2.81 | -0.39 | -1.39 | -0.03 |
EPS Diluted | -0.04 | -0.07 | -0.08 | -0.11 | -0.14 | -0.04 | -0.06 | -0.25 | -0.50 | -1.18 | -1.08 | -0.84 | -1.80 | -2.81 | -0.39 | -1.39 | -0.03 |
Weighted Avg Shares Out | 183.09M | 157.89M | 135.22M | 118.41M | 95.40M | 59.89M | 50.16M | 18.40M | 1.52M | 1.19M | 1.18M | 1.02M | 677.49K | 261.26K | 80.00K | 69.67K | 28.44K |
Weighted Avg Shares Out (Dil) | 183.09M | 157.89M | 135.22M | 118.41M | 95.40M | 59.89M | 50.16M | 18.40M | 1.52M | 1.19M | 1.18M | 1.02M | 677.49K | 261.26K | 80.00K | 69.67K | 28.44K |
Reliq Health Technologies, Inc. Announces Two New Contracts with US Nephrology Clinics
Reliq Health Technologies, Inc. Announces Two New Orthopedic Practice Contracts in the US
Reliq Health Technologies, Inc. Announces New Contract with Orthopedic Practice in Texas
Reliq Health Technologies Inc. to Present at Lytham Partners Spring 2021 Investor Conference
Reliq Health Technologies, Inc. Announces New Contract with a Physician Practice in Florida to Provide iUGO Care to over 25 Skilled Nursing Facilities
Reliq Health Technologies Inc. (RQHTF) CEO Lisa Crossley on Q2 2021 Results - Earnings Call Transcript
Reliq Health Technologies, Inc. Files Q2 FY2021 Financial Statements, Provides Corporate Update
Reliq Health Technologies, Inc. Announces Upcoming Shareholder Update Webinar
Reliq Health Technologies, Inc. Announces New Contract with US Nephrology Clinic to Provide iUGO Care to Chronic Kidney Disease Patients
Reliq Health Technologies, Inc. Announces New Contract with Care Management Network in California that includes 50 Clinics and over 500 Physicians
Source: https://incomestatements.info
Category: Stock Reports